Source abstract
Abstract
Recognition of folate and biotin surface receptors by dual-functionalized nanoparticles (NPs) is key for site-selective receptor-mediated transport of anticancer drugs to cancer cells. We present here dopamine-capped iron oxide nanoprobes (Fe3O4, 10 ± 2 nm) containing two surface-grafted biologically relevant ligands, namely, folic acid (FA) and biotin (BT). The covalent attachment of both FA and BT on Fe3O4 nanoparticles was achieved by following carbodiimide coupling and click-chemistry protocols. The dual-function Fe3O4 probes were delivered into E-G7 and human HeLa cancer cell lines and tested toward their cellular uptake by immunofluorescence and flow cytometry analysis. Owing to receptor-mediated endocytosis, enhanced accumulation of nanoprobes in cancer cells was successfully monitored by confocal laser microscopy. When compared to dual-function probes, single-functionalized nanoparticles possessing either FA or BT ligands showed significantly reduced uptake in the tested cell lines, underlining the superior interaction potential of dual-purpose probes. A time-dependent receptor-mediated endocytosis of FA–Fe3O4–BT nanovectors was demonstrated by flow cytometry analysis, whereas the unfunctionalized NPs did not show any specificity in terms of uptake. Besides their specific uptake, the surface-functionalized nanoparticles exhibited promising cytotoxicity profiles by demonstrating good viability of more than 95% with analogous cancer cell lines. Our results demonstrate that dual and/or multivariate conjugation of receptor-specific ligands on NPs is highly effective in molecular recognition of surface biomarkers that enhances their potential in anticancer treatment for pretargeting-radio strategies based on biotin/avidin interactions.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Institute of Inorganic Chemistry, University of Cologne, Greinstraße 6, 50939 Cologne, Germany
Professorship for Population Genetics, Department of Life Science Systems, Technical University of Munich, Liesel-Beckmann Straße 2, 85354 Freising, Germany
Center for Molecular Medicine Cologne and Translational Immunology, University Hospital Cologne, 50931 Cologne, Germany
Medical Microbiology, Immunology and Hygiene, University Hospital Cologne, Goldenfelsstraße 19-21, 50935 Cologne, Germany
Institute of Biochemistry I, Center for Molecular Medicine, University of Cologne, Joseph-Stelzmann-Straße 52, 50931 Cologne, Germany
Cologne Center for Genomics (CCG), University of Cologne, Weyertal 115b, 50931 Cologne, Germany
Funding
Universit?t zu K?ln